Original report. Pulse-spray thrombolysis of thrombosed hemodialysis grafts with tissue plasminogen activator.
OBJECTIVE
The purpose of this study was to evaluate pulse-spray pharmacomechanical thrombolysis with the use of tissue plasminogen activator in the recanalization of thrombosed hemodialysis access grafts.


CONCLUSIONS
Pulse-spray pharmacomechanical thrombolysis with tissue plasminogen activator is an effective method for percutaneous recanalization of thrombosed hemodialysis access grafts with results similar to other percutaneous techniques.
Cooper
Stanley G
SG
Department of Radiology, St. Luke's-Roosevelt Hospital Center, 1000 Tenth Ave., New York, NY 10019, USA.
D000368:Aged; D000369:Aged, 80 and over; D015901:Angiography, Digital Subtraction; D000800:Angioplasty, Balloon / Q000295:instrumentation; D001166:Arteriovenous Shunt, Surgical; D019917:Blood Vessel Prosthesis Implantation; D002408:Catheters, Indwelling; D003131:Combined Modality Therapy; D004867:Equipment Design; D005260:Female; D006083:Graft Occlusion, Vascular / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D007260:Infusion Pumps; D008297:Male; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care; D010865:Pilot Projects; D020551:Pulse Therapy, Drug; D006435:Renal Dialysis; D015912:Thrombolytic Therapy / Q000295:instrumentation*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
D010959:Tissue Plasminogen Activator